Dresser James van B. 4
4 · MERRIMACK PHARMACEUTICALS INC · Filed Apr 5, 2012
Insider Transaction Report
Form 4
Dresser James van B.
Director
Transactions
- Conversion
Common Stock
2012-04-03+11,111→ 98,611 total - Conversion
Common Stock
2012-04-03+4,901→ 103,512 total - Conversion
Series F Convertible Preferred Stock
2012-04-03−4,901→ 0 total→ Common Stock (4,901 underlying) - Conversion
Series E Convertible Preferred Stock
2012-04-03−11,111→ 0 total→ Common Stock (11,111 underlying)
Footnotes (2)
- [F1]Each share of Series E Convertible Preferred Stock automatically converted into one share of Common Stock upon the closing of the issuer's initial public offering and had no expiration date.
- [F2]Each share of Series F Convertible Preferred Stock automatically converted into one share of Common Stock upon the closing of the issuer's initial public offering and had no expiration date.